64Cu-labeled collagen specific peptides (Leidos)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Name64Cu-labeled collagen specific peptides (Leidos)
Drug Alias Name64Cu-NOTA-collagelin dimer64Cu-NOTA-CRPA
ClassificationRadiation-emitting productsBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionCollagen modulators
TargetsCollagen
Therapy Area/IndicationsFibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLeidos Biomedical Research Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsFibrosis

Other Information

ATC CodeN/A
Related LinksN/A